Cetera Investment Advisers
SANA icon

Cetera Investment Advisers’s Sana Biotechnology SANA Stock Holding History

Cetera Investment Advisers’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.1K Buy
26,383
+202
+0.8% +$651 ﹤0.01% 4678
2026
Q1 		$75.4K Buy
26,181
+8,750
+50% +$34.5K ﹤0.01% 4518
2025
Q4 		$70.9K Buy
17,431
+5,225
+43% +$23.4K ﹤0.01% 4466
2025
Q3 		$43.3K Buy
+12,206
New +$44.1K ﹤0.01% 4444
2024
Q3 		– Sell
-14,856
Closed -$81.1K – 3886
2024
Q2 		$81.1K Buy
+14,856
New +$118K ﹤0.01% 3549

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Cetera Investment Advisers's SANA Position: Q2 2026 in Review

Cetera Investment Advisers increased its Sana Biotechnology (SANA) stake by 0.77% in Q2 2026, buying an estimated $651 and bringing the position to 26,383 shares worth $92.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4678.

Cetera Investment Advisers first reported a position in SANA in Q2 2024 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Cetera Investment Advisers held 26,383 shares of Sana Biotechnology worth $92.1K as of Q2 2026.
  • Cetera Investment Advisers bought 202 Sana Biotechnology shares in Q2 2026, an estimated $651.
  • Sana Biotechnology made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4678 holding.
  • Cetera Investment Advisers first reported a position in Sana Biotechnology in Q2 2024 and has held it in 5 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.